Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Advertisement
Advertisement
›Stocks›PRGO

ETFs with exposure to Perrigo Co. Plc (PRGO)

95 ETFs hold Perrigo Co. Plc (PRGO)
Holdings data as of May 31, 2026
Sound Equity Income ETF - USD
This ETF provides exposure to Other Large and Mid-Cap US Equities
3.43%
+3.45%
+12.59%
€0
-€1.8M
€26M
0.45%
Not rated
Invesco High Yield Equity Dividend Achieversâ„¢ ETF - USD
This ETF provides exposure to Other US Equities
2.85%
+3.56%
+17.80%
-€3.2M
-€57M
€965M
0.54%
Invesco Dynamic Pharmaceuticals ETF - USD
This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities
2.13%
+9.54%
+13.11%
-€9.9M
-€204K
€311M
0.57%
State Street SPDR S&P Pharmaceuticals ETF - USD
This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities
2.04%
+13.95%
+16.85%
+€24M
+€119M
€371M
0.35%
Invesco S&P SmallCap High Dividend Low Volatility ETF - USD
This ETF provides exposure to Other Small Cap US Equities
1.97%
+5.26%
+13.78%
-€2.3M
-€3.4M
€64M
0.3%
Global X SuperDividend U.S. ETF - JPY
This ETF provides exposure to Equally Weighted US Equities
1.56%
+4.10%
+27.15%
-€390K
-€7.4M
€1.6M
0.475%
Not rated
Global X SuperDividend U.S. ETF - USD
This ETF provides exposure to Equally Weighted US Equities
1.56%
+1.02%
+13.74%
+€2.5M
+€30M
€660M
0.45%
Invesco S&P SmallCap Health Care ETF - USD
This ETF provides exposure to Small Cap US Health Care Equities
0.82%
+17.74%
+19.80%
+€5.7M
-€9.9M
€141M
0.29%
Invesco S&P SmallCap 600® Pure Value ETF - USD
This ETF provides exposure to Other Small Cap US Equities
0.76%
+7.07%
+26.50%
€0
+€3.7M
€250M
0.35%
iShares U.S. Pharmaceuticals ETF - USD
This ETF provides exposure to US Pharmaceuticals Equities
0.41%
+9.19%
+16.62%
+€134M
+€128M
€997M
0.38%
See more results with a Trackinsight account
Get started with a free Essentials account today.
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight